TLR4 and Alzheimer disease: For example, a genetic study proposed that a polymorphism in TLR4 (Asp299Gly) may decrease the risk of AD independently of a polymorphism in apolipoprotein E, suggesting the involvement of the innate immunity in neurodegeneration in general, and of TLR4 in AD, in particular [14, 15].